Sign In
Buy AKBA
Akebia Therapeutics Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be positive at 3.10. In total, the insiders bought 10.48M and sold 1.18M AKBA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
3.10 |
| ● Buy | 10.48M shares |
| ● Sell | 1.18M shares |
|
69% Buy Activity
Weak Negative Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Jun 09, 2025 Buy |
Malabre Richard C SVP, Chief Accounting Officer |
15 000 Value: $25.2K |
||
|
Jun 04, 2025 Sell |
Malabre Richard C SVP, Chief Accounting Officer |
13 334 Value: $47.1K |
||
|
Jun 04, 2025 Sell |
Malabre Richard C SVP, Chief Accounting Officer |
13 334 Value: $47.1K |
||
|
Mar 03, 2025 Sell |
Butler John P. CEO And President |
46 409 Value: $84.9K |
||
|
Mar 03, 2025 Sell |
Burke Steven Keith SVP, Chief Medical Officer |
7 144 Value: $13.1K |
||
|
Mar 03, 2025 Sell |
Burke Steven Keith SVP, Chief Medical Officer |
7 144 Value: $13.1K |
||
|
Mar 03, 2025 Sell |
Butler John P. CEO And President |
46 409 Value: $84.9K |
||
|
Feb 03, 2025 Sell |
Butler John P. CEO And President |
46 268 Value: $97.2K |
||
|
Feb 03, 2025 Sell |
Butler John P. CEO And President |
97 982 Value: $205.8K |
||
|
Feb 03, 2025 Sell |
Burke Steven Keith SVP, Chief Medical Officer |
23 270 Value: $48.9K |
||
|
Feb 03, 2025 Sell |
Burke Steven Keith SVP, Chief Medical Officer |
27 236 Value: $57.2K |
||
|
Feb 03, 2025 Sell |
Malabre Richard C SVP, Chief Accounting Officer |
30 202 Value: $63.4K |
||
|
Feb 03, 2025 Sell |
Grund Nicholas Chief Commercial Officer |
55 621 Value: $116.8K |
||
|
Jan 31, 2025 Buy |
Butler John P. CEO And President |
701 000 Value: $1.57M |
||
|
Jan 31, 2025 Buy |
Butler John P. CEO And President |
1 051 400 Value: $2.36M |
||
|
Jan 31, 2025 Buy |
Butler John P. CEO And President |
350 500 Value: $785.1K |
||
|
Jan 31, 2025 Buy |
Burke Steven Keith SVP, Chief Medical Officer |
194 900 Value: $436.6K |
||
|
Jan 31, 2025 Buy |
Burke Steven Keith SVP, Chief Medical Officer |
292 300 Value: $654.8K |
||
|
Jan 31, 2025 Buy |
Malabre Richard C SVP, Chief Accounting Officer |
85 000 Value: $190.4K |
||
|
Jan 31, 2025 Buy |
Malabre Richard C SVP, Chief Accounting Officer |
128 000 Value: $286.7K |
||
|
Jan 31, 2025 Buy |
Ostrowski Erik SVP, CFO, Cbo & Treasurer |
292 300 Value: $654.8K |
||
|
Jan 31, 2025 Buy |
Ostrowski Erik SVP, CFO, Cbo & Treasurer |
194 900 Value: $436.6K |
||
|
Jan 31, 2025 Buy |
Grund Nicholas Chief Commercial Officer |
292 300 Value: $654.8K |
||
|
Jan 31, 2025 Buy |
Grund Nicholas Chief Commercial Officer |
194 900 Value: $436.6K |
||
|
Jan 31, 2025 Buy |
Malabre Richard C SVP, Chief Accounting Officer |
128 000 Value: $286.7K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
